BioChip Journal

, Volume 8, Issue 3, pp 163–170 | Cite as

Transcriptomic analysis of effects of triclosan on Mycobacterium bovis BCG

Original Article
First Online:
Received:
Accepted:

Abstract

Tuberculosis is a leading cause of death worldwide and infects thousands of Americans annually. Triclosan (TCS) is used as an oxidative antibacterial in household products such as disinfectants, soaps, detergents, toothpaste. This study presents for the first time, the transcriptomic changes in M. bovis BCG after treatment with 0.1 mM TCS for 10 and 60 min. The results after 10 min exposure to TCS show up-regulations of three groups of functional classes genes in M. bovis BCG. First group are hyc group (hycD, hysP, hysQ, and hysE), which is related to energy production and conversion. Second group is related to oxidation stress of many metabolites, especially, accA2, accD2, fadE12, and fadE13. Third group is associated with ppe family which is distinctive to mycobacteria (ppe3, ppe18, and ppe61). After 60 min exposure the following genes were drastically down-regulated ppe61, hycD hycQ, and bcg0232, which express luxR family two component transcriptional regulators.

Keywords

Mycobacterium bovis BCG Triclosan Microarray Antimycobacterial Hydrogenase Proline-Proline-Glutamic acid (PPE) 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Nde C.W., Toghrol F., Jang H.J. & Bentley W.E. Toxicogenomic response of Mycobacterium bovis BCG to peracetic acid and a comparative analysis of the M. bovis BCG response to three oxidative disinfectants. Appl. Microbiol. Biotechnol. 90, 277–304 (2010).CrossRefGoogle Scholar
  2. 2.
    Dye C. & Williams B.G. The population dynamics and control of tuberculosis. Science 328, 856–861 (2010).CrossRefGoogle Scholar
  3. 3.
    World Health Organization Global tuberculosis control: a short update to the 2009 report (2009).Google Scholar
  4. 4.
    Hope J.C. & Villarreal-Ramos B. Bovine TB and the development of new vaccines. Comp Immunol. Microbiol. Infect Dis. 31, 77–100 (2008).Google Scholar
  5. 5.
    Koul A., Arnoult E., Lounis N., Guillemont J. & Andries K. The challenge of new drug discovery for tuberculosis. Nature 469, 483–490 (2011).CrossRefGoogle Scholar
  6. 6.
    Garnier T. et al. The complete genome sequence of Mycobacterium bovis. Proc. Natl. Acad. Sci. U.S.A. 100, 7877–7882 (2003).CrossRefGoogle Scholar
  7. 7.
    Hontela, AB. Triclosan: environmental exposure, toxicity and mechanisms of action. J. Appl. Toxicol. (2011).Google Scholar
  8. 8.
    Campbell L. & Zirwas M.J. Triclosan. Dermatitis 17, 204–207 (2006).CrossRefGoogle Scholar
  9. 9.
    Russell A.D. Whither triclosan? J. Antimicrob. Chemother. 53, 693–695 (2004).CrossRefGoogle Scholar
  10. 10.
    McMurry L.M., Oethinger M. & Levy S.B. Triclosan targets lipid synthesis. Nature 394, 531–532 (1998).CrossRefGoogle Scholar
  11. 11.
    Levy C.W. et al. Molecular basis of triclosan activity. Nature 398, 383–384 (1999).CrossRefGoogle Scholar
  12. 12.
    Kim K.S. et al. The Multi-Targeted Effects of Chrysanthemum Herb Extract Against Escherichia coli O157:H7. Phytother. Res. 27, 1398–1406 (2013).CrossRefGoogle Scholar
  13. 13.
    Mertens R. & Liese A. Biotechnological applications of hydrogenases. Curr. Opin. Biotechnol. 15, 343–348 (2004).CrossRefGoogle Scholar
  14. 14.
    Wu X., Liang Y., Li Q., Zhou J. & Long M. Characterization and cloning of oxygen-tolerant hydrogenase from Klebsiella oxytoca HP1. Res. Microbiol. 162, 330–336 (2011).CrossRefGoogle Scholar
  15. 15.
    Cole S.T. et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537–544 (1998).CrossRefGoogle Scholar
  16. 16.
    Saini D.K. et al. DevR-DevS is a bona fide two-component system of Mycobacterium tuberculosis that is hypoxia-responsive in the absence of the DNA-binding domain of DevR. Microbiology 150, 865–875 (2004).CrossRefGoogle Scholar
  17. 17.
    Bagchi G., Chauhan S., Sharma D. & Tyagi J.S. Transcription and autoregulation of the Rv3134c-devRdevS operon of Mycobacterium tuberculosis. Microbiology 151, 4045–4053 (2005).CrossRefGoogle Scholar
  18. 18.
    Boon C., Li R., Qi R. & Dick T. Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model. J. Bacteriol. 183, 2672–2676 (2001).CrossRefGoogle Scholar
  19. 19.
    Goldstone R.M., Goonesekera S.D., Bloom B.R. & Sampson S.L. The transcriptional regulator Rv0485 modulates the expression of a pe and ppe gene pair and is required for Mycobacterium tuberculosis virulence. Infect. Immun. 77, 4654–4667 (2009).CrossRefGoogle Scholar
  20. 20.
    Karboul A. et al. Frequent homologous recombination events in Mycobacterium tuberculosis PE/PPE multigene families: potential role in antigenic variability. J. Bacteriol. 190, 7838–7846 (2008).CrossRefGoogle Scholar
  21. 21.
    Ohno H. et al. The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis. Cell. Microbiol. 5, 637–648 (2003).CrossRefGoogle Scholar
  22. 22.
    Sherman D.R. et al. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alphacrystallin. Proc. Natl. Acad. Sci. U.S.A. 98, 7534–7539 (2001).CrossRefGoogle Scholar
  23. 23.
    Reis M.C., Rabahi M.F., Kipnis A. & Junqueira- Kipnis A.P. Health care workers humoral immune response against GLcB, MPT51 and HSPX from Mycobacterium tuberculosis. Braz. J. Infect. Dis. 13, 417–421 (2009).CrossRefGoogle Scholar
  24. 24.
    Spratt J.M., Britton W.J. & Triccas J.A. In vivo persistence and protective efficacy of the bacille Calmette Guerin vaccine overexpressing the HspX latency antigen. Bioeng. Bugs. 1, 61–65 (2010).CrossRefGoogle Scholar
  25. 25.
    de Haan J.R. et al. Interpretation of ANOVA models for microarray data using PCA. Bioinformatics 23, 184–190 (2007).CrossRefGoogle Scholar
  26. 26.
    Chang W., Small D.A., Toghrol F. & Bentley W.E. Global transcriptome analysis of Staphylococcus aureus response to hydrogen peroxide. J. Bacteriol. 188, 1648–1659 (2006).CrossRefGoogle Scholar
  27. 27.
    Ahn M.J., Koh R.K., Kim G.O. & Shin T.K. Aqueous extract of purple Bordeaux radish, Raphanus sativus L. ameliorates ethanol-induced gastric injury in rats. Oriental Pharm. Exp. Med. 13, 247–252 (2013).CrossRefGoogle Scholar
  28. 28.
    Jang H.J., Chang M.W., Toghrol F. & Bentley W.E. Microarray analysis of toxicogenomic effects of triclosan on Staphylococcus aureus. Appl. Microbiol. Biotechnol. 78, 695–707 (2008).CrossRefGoogle Scholar
  29. 29.
    Nde C.W., Jang H.J., Toghrol F. & Bentley W.E. Toxicogenomic response of Pseudomonas aeruginosa to ortho-phenylphenol. BMC Genomics 9, 473 (2008).CrossRefGoogle Scholar
  30. 30.
    Kim K.H. et al. Aqueous extracts of Anemarrhena asphodeloides stimulate glucagon-like pepetide-1 secretion in enteroendocrine NCI-H716 cells. BioChip J. 7, 188–193 (2013).CrossRefGoogle Scholar

Copyright information

© The Korean BioChip Society and Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Nursing Department, College of Health ScienceKangwon UniversityChuncheonKorea
  2. 2.Department of Biochemistry, College of Korean MedicineKyung Hee UniversitySeoulKorea

Personalised recommendations